CAFs can also promote the survival, activation, and function of neutrophils through an IL6-STAT3-PDL1 signaling cascade, impairing T-cell function through the PD1/PDL1 signaling pathway as reported in hepatocellular carcinoma (HCC) [49, 50]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.